Cargando…
Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation
The impact of consolidation on response rates and PFS has recently been demonstrated after induction and autotransplantation upfront in Multiple Myeloma (MM). We further showed that patients in ≥VGPR following the intensification procedure benefited most from consolidation. Question remains as to th...
Autores principales: | Fouquet, Guillemette, Hebraud, Benjamin, Garciaz, Sylvain, Stoppa, Anne Marie, Roussel, Murielle, Caillot, Denis, Chrétien, Marie Lorraine, Arnulf, Bertrand, Szalat, Raphael, Garderet, Laurent, Benajiba, Lina, Pegourie, Brigitte, Regny, Caroline, Royer, Bruno, Caulier, Alexis, Touzeau, Cyrille, Tessoulin, Benoit, Fermand, Jean Paul, Facon, Thierry, Attal, Michel, Loiseau, Hervé Avet, Moreau, Philippe, Leleu, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963082/ https://www.ncbi.nlm.nih.gov/pubmed/24665349 http://dx.doi.org/10.7150/jca.8541 |
Ejemplares similares
-
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligible patients with newly diagnosed multiple myeloma, using propensity score matching
por: Moreau, Philippe, et al.
Publicado: (2020) -
Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
por: Lee, Yoo Jin, et al.
Publicado: (2019) -
Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible
por: Sonneveld, Pieter, et al.
Publicado: (2020) -
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
por: Ghandili, Susanne, et al.
Publicado: (2022) -
Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis
por: Srkalovic, Gordan, et al.
Publicado: (2005)